Home › Urogenital Cancer › Nebraska
Urogenital Cancer clinical trials in Nebraska
3 studies for Urogenital Cancer are looking for participants at sites in Nebraska.
Cities in Nebraska
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Urology Cancer Center, PC, Omaha
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT06800313Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- XCancer Omaha / Urology Cancer Center, Omaha
RecruitingPhase 1/2
Ages 18 and older · Men · Updated May 14, 2026 · NCT05413850From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.